TrialLeukemia2015

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.

D J DeAngelo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.